Topic

New Jersey

A collection of 536 issues

How to Get Xospata (gilteritinib) Covered by Aetna (CVS Health) in New Jersey: Prior Authorization, Appeals, and Success Strategies

Answer Box: Getting Xospata Covered in New Jersey Xospata (gilteritinib) requires prior authorization from Aetna (CVS Health) in New Jersey for FLT3-mutated relapsed/refractory AML. Submit through the Availity portal at least 2 weeks before treatment, including FLT3 mutation test results, prior therapy documentation, and medical necessity letter. If denied,

Hetlioz LQ (Tasimelteon Oral Suspension) Cigna Coverage in New Jersey: Complete Prior Authorization Guide and Appeals Process

Answer Box: Getting Hetlioz LQ (Tasimelteon Oral Suspension) Covered by Cigna in New Jersey Cigna covers Hetlioz LQ for pediatric patients (ages 3-15) with Smith-Magenis syndrome in New Jersey, but requires prior authorization with strict documentation. The fastest path to approval: 1) Confirm SMS diagnosis with genetic testing, 2) Document

How to Get Duopa Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Duopa Covered by Blue Cross Blue Shield in New Jersey Duopa requires prior authorization from Blue Cross Blue Shield in New Jersey under the medical benefit (not pharmacy). Submit through your neurologist with documented advanced Parkinson's disease, ≥2-3 hours daily "OFF" time, failed

How to Get Humate-P Covered by Aetna CVS Health in New Jersey: Complete Forms, Appeals & Portal Guide

Answer Box: Getting Humate-P Covered by Aetna CVS Health in New Jersey Humate-P requires prior authorization from Aetna CVS Health for hemophilia A and von Willebrand disease treatment. Fastest approval path: Submit PA request via Aetna provider portal with recent VWF/Factor VIII labs, diagnosis confirmation, and desmopressin trial documentation

How to Get Synagis (Palivizumab) Covered by Humana in New Jersey: Complete PA Guide and Appeals Process

Quick Answer: Synagis (palivizumab) requires prior authorization from Humana in New Jersey. High-risk infants under 12 months with specific conditions (prematurity ≤35 weeks, chronic lung disease, congenital heart disease) are eligible. Submit Humana's Antiviral Monoclonal Antibodies PA form with clinical documentation. If denied, you have 65 days to

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Aetna CVS Health in New Jersey: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Enhertu Covered by Aetna CVS Health in New Jersey Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved indications. The fastest path to approval: 1) Submit complete PA request with HER2 biomarker testing, prior therapy documentation, and ILD monitoring plan via Aetna provider

Mavenclad (Cladribine) Approval with Aetna CVS Health in New Jersey: Complete Coverage Guide

Answer Box: Getting Mavenclad Covered by Aetna CVS Health in New Jersey Yes, Mavenclad (cladribine tablets) is covered by Aetna CVS Health in New Jersey with prior authorization for relapsing forms of multiple sclerosis. You need documented failure of at least two disease-modifying therapies and baseline lymphocyte count ≥800 cells/

Work With Your Doctor to Get Exondys 51 (eteplirsen) Covered by UnitedHealthcare in New Jersey: Complete Guide

Answer Box: Getting Exondys 51 Covered by UnitedHealthcare in New Jersey Eligibility: Exondys 51 requires prior authorization from UnitedHealthcare for patients with Duchenne muscular dystrophy (DMD) and a confirmed mutation amenable to exon 51 skipping. Fastest approval path: 1. Ensure prescriber is a neurologist with DMD expertise 2. Gather genetic

How to Get Haegarda (C1-esterase inhibitor, SC) Covered by Aetna (CVS Health) in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Haegarda Covered by Aetna (CVS Health) in New Jersey Haegarda requires prior authorization from Aetna (CVS Health) in New Jersey. Your fastest path: 1) Have your HAE specialist complete Aetna's precertification form with HAE diagnosis confirmation (C1-INH deficiency labs), attack frequency documentation, and any prior

Getting Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in New Jersey: Complete 2025 Guide with Forms and Appeals

Answer Box: Your Path to Strimvelis Coverage in New Jersey Strimvelis gene therapy coverage through Blue Cross Blue Shield in New Jersey requires a medical exception request due to its Milan-only availability and lack of FDA approval. Success depends on thorough documentation of ADA-SCID diagnosis, failed standard treatments, and medical